Harmony Biosciences Swings to Q1 Adjusted Earnings as Revenue Triples
08:37 AM EDT, 05/11/2021 (MT Newswires) -- Harmony Biosciences Holdings (HRMY) on Tuesday reported Q1 adjusted EPS of $0.38, compared with an adjusted loss of $2.14 per share last year. Analysts polled by Capital IQ had called for $0.02 loss per share.
The US pharmaceutical company reported revenue of $59.7 million for the March quarter, nearly tripled compared with $19.8 million a year ago. Wall Street was looking for $57.2 million.
Harmony also said it ended Q1 with $141.2 million of cash and cash equivalents, compared with $228.6 million at the end of Q4.
Price: 26.80, Change: -0.92, Percent Change: -3.32